The global Heart-on-a-chip market is projected to reach US$ million by 2030.
By "Heart-on-a-chip" technology - simulating the human heart on an engineering chip and using microelectrodes to measure the effects of compound exposure, it is possible to ensure that potential life-saving new drugs are safe and effective, while reducing the need for humans and animal testing.
This report contains market size and forecasts of Heart-on-a-chip in Global, including the following market information:
Global Heart-on-a-chip Market Size 2025-2030, ($ millions)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Heart-on-a-chip companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Heart-on-a-chip Market, by Type, 2025-2030 ($ millions)
Global Heart-on-a-chip Market Segment Percentages, by Type
- Children Heart-on-a-chip
- Adult Heart-on-a-chip
Global Heart-on-a-chip Market, by Application, 2025-2030 ($ millions)
Global Heart-on-a-chip Market Segment Percentages, by Application
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Other End Users
Global Heart-on-a-chip Market, By Region and Country, 2025-2030 ($ Millions)
Global Heart-on-a-chip Market Segment Percentages, by region and country
- United States
- Europe
- Asia
- China
- Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
- Emulate
- Tissuse
- Hesperos
- CN Bio Innovations
- Draper Laboratory
- Mimetas
- Nortis
- Kirkstall
- Cherry Biotech SAS
- Else Else Kooi Laboratory
- Micronit Microtechnologies B.V.
- Tara Biosystems
